Chinese General Practice ›› 2024, Vol. 27 ›› Issue (26): 3240-3248.DOI: 10.12114/j.issn.1007-9572.2023.0920
• Original Research • Previous Articles Next Articles
Received:
2024-03-10
Revised:
2024-04-10
Published:
2024-09-15
Online:
2024-06-14
Contact:
FAN Xiaonong
通讯作者:
樊小农
作者简介:
作者贡献:
李宋姣、常颖慧、樊小农、李礼、杜宇征、刘健、沈燕负责研究设计;雷康辰、黄泓文负责调查问卷制作;李宋姣、雷康辰、黄泓文、宋佳丽、常颖慧、边丽娜、孟丽娜、宋倩、高莹、麻聪聪负责研究实施;李宋姣、雷康辰、宋佳丽、蔡欣儒负责数据收集;李宋姣负责数据统计分析、结果呈现、论文撰写;樊小农负责研究质量控制、论文写作指导、文章质量控制及审校,并对文章整体负责;葛文逸、刘巍、李仪丙、贾鸿博、雷康辰负责论文修改。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0920
一般资料 | 长新冠(n=585) | 非长新冠(n=316) | χ2值 | P值 |
---|---|---|---|---|
性别 | 21.650 | <0.001 | ||
男 | 138(23.59) | 121(38.29) | ||
女 | 447(76.41) | 195(61.71) | ||
年龄(岁) | 4.092 | 0.252 | ||
≤17 | 9(1.54) | 6(1.90) | ||
18~45 | 324(55.38) | 186(58.86) | ||
46~69 | 219(37.44) | 115(36.39) | ||
≥70 | 33(5.64) | 9(2.85) | ||
基础病 | ||||
患有高血压 | 0.645 | 0.422 | ||
是 | 81(13.85) | 50(15.82) | ||
否 | 504(86.15) | 266(84.18) | ||
患有糖尿病 | 0.084 | 0.772 | ||
是 | 36(6.15) | 21(6.65) | ||
否 | 549(93.85) | 295(93.35) | ||
患有免疫系统疾病 | 5.510 | 0.019 | ||
是 | 27(4.62) | 5(1.58) | ||
否 | 558(95.38) | 311(98.42) | ||
患有肿瘤 | 8.567 | 0.003 | ||
是 | 27(4.62) | 3(0.95) | ||
否 | 558(95.38) | 313(99.05) | ||
患有慢性心源性疾病 | 0.108 | 0.742 | ||
是 | 25(4.27) | 15(4.75) | ||
否 | 560(95.73) | 301(95.25) | ||
患有慢性呼吸系统疾病 | 3.483 | 0.062 | ||
是 | 25(4.27) | 6(1.90) | ||
否 | 560(95.73) | 310(98.10) | ||
患有慢性肾源性疾病 | 4.360 | 0.037 | ||
是 | 8(1.37) | 0 | ||
否 | 577(98.63) | 316(100.00) | ||
职业 | ||||
医疗机构工作人员 | 1.449 | 0.229 | ||
是 | 161(27.52) | 99(31.33) | ||
否 | 424(72.48) | 217(68.67) | ||
退休人员 | 8.837 | 0.003 | ||
是 | 138(23.59) | 48(15.19) | ||
否 | 447(76.41) | 268(84.81) | ||
国家机关、党群组织、企业事业单位从业者 | 0.266 | 0.606 | ||
是 | 87(14.87) | 43(13.61) | ||
否 | 498(85.13) | 273(86.39) | ||
学生 | 5.732 | 0.017 | ||
是 | 41(7.01) | 37(11.71) | ||
否 | 544(92.99) | 279(88.29) | ||
服务行业 | 0.442 | 0.506 | ||
是 | 46(7.86) | 21(6.65) | ||
否 | 539(92.14) | 295(93.35) | ||
重体力劳动者(工厂职工、建筑工人) | 1.637 | 0.201 | ||
是 | 15(2.56) | 13(4.11) | ||
否 | 570(97.44) | 303(95.89) | ||
基层工作人员(社区工作者、警察) | 1.509 | 0.219 | ||
是 | 3(0.51) | 4(1.27) | ||
否 | 582(99.49) | 312(98.73) | ||
其他(交通运输等) | 0.001 | 0.978 | ||
是 | 94(16.07) | 51(16.14) | ||
否 | 491(83.93) | 265(83.86) |
Table 1 Comparison of general data between patients with long COVID and non-long COVID
一般资料 | 长新冠(n=585) | 非长新冠(n=316) | χ2值 | P值 |
---|---|---|---|---|
性别 | 21.650 | <0.001 | ||
男 | 138(23.59) | 121(38.29) | ||
女 | 447(76.41) | 195(61.71) | ||
年龄(岁) | 4.092 | 0.252 | ||
≤17 | 9(1.54) | 6(1.90) | ||
18~45 | 324(55.38) | 186(58.86) | ||
46~69 | 219(37.44) | 115(36.39) | ||
≥70 | 33(5.64) | 9(2.85) | ||
基础病 | ||||
患有高血压 | 0.645 | 0.422 | ||
是 | 81(13.85) | 50(15.82) | ||
否 | 504(86.15) | 266(84.18) | ||
患有糖尿病 | 0.084 | 0.772 | ||
是 | 36(6.15) | 21(6.65) | ||
否 | 549(93.85) | 295(93.35) | ||
患有免疫系统疾病 | 5.510 | 0.019 | ||
是 | 27(4.62) | 5(1.58) | ||
否 | 558(95.38) | 311(98.42) | ||
患有肿瘤 | 8.567 | 0.003 | ||
是 | 27(4.62) | 3(0.95) | ||
否 | 558(95.38) | 313(99.05) | ||
患有慢性心源性疾病 | 0.108 | 0.742 | ||
是 | 25(4.27) | 15(4.75) | ||
否 | 560(95.73) | 301(95.25) | ||
患有慢性呼吸系统疾病 | 3.483 | 0.062 | ||
是 | 25(4.27) | 6(1.90) | ||
否 | 560(95.73) | 310(98.10) | ||
患有慢性肾源性疾病 | 4.360 | 0.037 | ||
是 | 8(1.37) | 0 | ||
否 | 577(98.63) | 316(100.00) | ||
职业 | ||||
医疗机构工作人员 | 1.449 | 0.229 | ||
是 | 161(27.52) | 99(31.33) | ||
否 | 424(72.48) | 217(68.67) | ||
退休人员 | 8.837 | 0.003 | ||
是 | 138(23.59) | 48(15.19) | ||
否 | 447(76.41) | 268(84.81) | ||
国家机关、党群组织、企业事业单位从业者 | 0.266 | 0.606 | ||
是 | 87(14.87) | 43(13.61) | ||
否 | 498(85.13) | 273(86.39) | ||
学生 | 5.732 | 0.017 | ||
是 | 41(7.01) | 37(11.71) | ||
否 | 544(92.99) | 279(88.29) | ||
服务行业 | 0.442 | 0.506 | ||
是 | 46(7.86) | 21(6.65) | ||
否 | 539(92.14) | 295(93.35) | ||
重体力劳动者(工厂职工、建筑工人) | 1.637 | 0.201 | ||
是 | 15(2.56) | 13(4.11) | ||
否 | 570(97.44) | 303(95.89) | ||
基层工作人员(社区工作者、警察) | 1.509 | 0.219 | ||
是 | 3(0.51) | 4(1.27) | ||
否 | 582(99.49) | 312(98.73) | ||
其他(交通运输等) | 0.001 | 0.978 | ||
是 | 94(16.07) | 51(16.14) | ||
否 | 491(83.93) | 265(83.86) |
影响因素 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
性别(以男性为参照) | ||||||
女性 | 0.693 | 0.154 | 20.114 | <0.001 | 2.000 | 1.477~2.705 |
慢性肾源性疾病(以否为参照) | ||||||
是 | 20.289 | 13 847.549 | <0.001 | 1.000 | 647 438 869.898 | 0a |
免疫系统疾病(以否为参照) | ||||||
是 | 0.923 | 0.500 | 3.402 | 0.065 | 2.517 | 0.944~6.710 |
肿瘤(以否为参照) | ||||||
是 | 1.487 | 0.618 | 5.782 | 0.016 | 4.424 | 1.316~14.868 |
退休人员(以否为参照) | ||||||
是 | 0.423 | 0.192 | 4.859 | 0.028 | 1.527 | 1.048~2.224 |
学生(以否为参照) | ||||||
是 | -0.440 | 0.246 | 3.197 | 0.074 | 0.644 | 0.398~1.043 |
Table 2 Binary Logistic regression analysis on the influencing factors for long COVID
影响因素 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
性别(以男性为参照) | ||||||
女性 | 0.693 | 0.154 | 20.114 | <0.001 | 2.000 | 1.477~2.705 |
慢性肾源性疾病(以否为参照) | ||||||
是 | 20.289 | 13 847.549 | <0.001 | 1.000 | 647 438 869.898 | 0a |
免疫系统疾病(以否为参照) | ||||||
是 | 0.923 | 0.500 | 3.402 | 0.065 | 2.517 | 0.944~6.710 |
肿瘤(以否为参照) | ||||||
是 | 1.487 | 0.618 | 5.782 | 0.016 | 4.424 | 1.316~14.868 |
退休人员(以否为参照) | ||||||
是 | 0.423 | 0.192 | 4.859 | 0.028 | 1.527 | 1.048~2.224 |
学生(以否为参照) | ||||||
是 | -0.440 | 0.246 | 3.197 | 0.074 | 0.644 | 0.398~1.043 |
症状和体征 | 新冠感染人数 | 自愈难度c(恢复期人数/急性期人数) | |||||
---|---|---|---|---|---|---|---|
急性期a(n=901) | 恢复期(长新冠)b(n=585) | ||||||
人数 | 排名 | 人数 | 排名 | 所占比例(%) | 排名 | ||
神经 | 记忆力理解力注意力降低 | 512 | 9 | 274 | 2 | 53.52 | 2 |
嗅觉味觉减退或丧失 | 461 | 11 | 62 | 14 | 13.45 | 15 | |
精神 | 失眠 | 434 | 12 | 217 | 3 | 50.00 | 3 |
情绪低落、焦虑、烦躁 | 433 | 13 | 197 | 6 | 45.50 | 5 | |
心血管 | 心慌、心悸 | 487 | 10 | 207 | 4 | 42.51 | 7 |
呼吸 | 咳嗽 | 739 | 3 | 158 | 7 | 21.38 | 11 |
呼吸急促困难 | 317 | 14 | 81 | 11 | 25.55 | 10 | |
鼻塞 | 552 | 7 | 73 | 13 | 13.22 | 16 | |
咽痛 | 609 | 5 | 57 | 15 | 9.36 | 17 | |
胃肠道 | 腹泻、腹痛 | 246 | 15 | 42 | 17 | 17.07 | 13 |
呕吐 | 183 | 17 | 17 | 18 | 9.29 | 18 | |
皮肤 | 脱发 | 210 | 16 | 123 | 8 | 58.57 | 1 |
皮疹 | 121 | 19 | 50 | 16 | 41.32 | 8 | |
肌肉骨骼肌 | 腰背痛 | 617 | 4 | 201 | 5 | 32.58 | 9 |
四肢肌痛 | 558 | 6 | 101 | 9 | 18.10 | 12 | |
头痛 | 551 | 8 | 82 | 10 | 14.88 | 14 | |
其他 | 发热 | 778 | 1 | 19 | 19 | 1.41 | 19 |
疲劳 | 767 | 2 | 341 | 1 | 44.46 | 6 | |
月经不调 | 163 | 18 | 75 | 12 | 46.01 | 4 |
Table 3 Rankings of new symptoms and signs in the acute and convalescent stages of COVID-19 and the difficulty of self-healing
症状和体征 | 新冠感染人数 | 自愈难度c(恢复期人数/急性期人数) | |||||
---|---|---|---|---|---|---|---|
急性期a(n=901) | 恢复期(长新冠)b(n=585) | ||||||
人数 | 排名 | 人数 | 排名 | 所占比例(%) | 排名 | ||
神经 | 记忆力理解力注意力降低 | 512 | 9 | 274 | 2 | 53.52 | 2 |
嗅觉味觉减退或丧失 | 461 | 11 | 62 | 14 | 13.45 | 15 | |
精神 | 失眠 | 434 | 12 | 217 | 3 | 50.00 | 3 |
情绪低落、焦虑、烦躁 | 433 | 13 | 197 | 6 | 45.50 | 5 | |
心血管 | 心慌、心悸 | 487 | 10 | 207 | 4 | 42.51 | 7 |
呼吸 | 咳嗽 | 739 | 3 | 158 | 7 | 21.38 | 11 |
呼吸急促困难 | 317 | 14 | 81 | 11 | 25.55 | 10 | |
鼻塞 | 552 | 7 | 73 | 13 | 13.22 | 16 | |
咽痛 | 609 | 5 | 57 | 15 | 9.36 | 17 | |
胃肠道 | 腹泻、腹痛 | 246 | 15 | 42 | 17 | 17.07 | 13 |
呕吐 | 183 | 17 | 17 | 18 | 9.29 | 18 | |
皮肤 | 脱发 | 210 | 16 | 123 | 8 | 58.57 | 1 |
皮疹 | 121 | 19 | 50 | 16 | 41.32 | 8 | |
肌肉骨骼肌 | 腰背痛 | 617 | 4 | 201 | 5 | 32.58 | 9 |
四肢肌痛 | 558 | 6 | 101 | 9 | 18.10 | 12 | |
头痛 | 551 | 8 | 82 | 10 | 14.88 | 14 | |
其他 | 发热 | 778 | 1 | 19 | 19 | 1.41 | 19 |
疲劳 | 767 | 2 | 341 | 1 | 44.46 | 6 | |
月经不调 | 163 | 18 | 75 | 12 | 46.01 | 4 |
症状和体征 | 疲劳患者a(n=341) | 脱发患者b(n=123) | 记忆力理解力注意力降低患者c(n=274) | 失眠患者d(n=217) | 腰背痛患者e(n=201) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | ||
神经 | 记忆力理解力注意力降低 | 56.30 | 1 | 62.60 | 2 | 61.75 | 2 | 65.67 | 2 | ||
嗅觉味觉减退或丧失 | 11.73 | 13 | 17.89 | 14 | 14.96 | 12 | 11.06 | 15 | 12.94 | 14 | |
精神 | 失眠 | 47.80 | 2 | 47.15 | 3 | 48.91 | 4 | 52.24 | 3 | ||
情绪低落、焦虑、烦躁 | 40.76 | 5 | 45.53 | 4 | 53.28 | 2 | 57.60 | 3 | 44.28 | 5 | |
心血管 | 心慌、心悸 | 44.28 | 3 | 43.90 | 6 | 50.00 | 3 | 53.46 | 4 | 50.25 | 4 |
呼吸 | 咳嗽 | 31.96 | 6 | 22.76 | 9 | 25.18 | 8 | 28.57 | 6 | 30.35 | 7 |
呼吸急促困难 | 15.54 | 10 | 17.89 | 13 | 21.17 | 10 | 22.58 | 10 | 19.40 | 10 | |
鼻塞 | 15.54 | 11 | 22.76 | 10 | 20.07 | 11 | 18.43 | 11 | 14.93 | 12 | |
咽痛 | 15.54 | 12 | 13.82 | 15 | 13.14 | 14 | 11.98 | 14 | 15.42 | 11 | |
胃肠道 | 腹泻、腹痛 | 7.62 | 16 | 12.20 | 16 | 9.49 | 16 | 11.06 | 16 | 10.45 | 16 |
呕吐 | 2.64 | 17 | 4.88 | 17 | 3.28 | 17 | 3.23 | 17 | 2.49 | 17 | |
皮肤 | 脱发 | 23.57 | 7 | 28.10 | 7 | 26.73 | 8 | 27.36 | 8 | ||
皮疹 | 13.58 | 15 | 21.14 | 11 | 11.68 | 15 | 12.90 | 12 | 12.44 | 15 | |
肌肉骨骼肌 | 腰背痛 | 69.25 | 4 | 44.72 | 5 | 48.18 | 5 | 48.39 | 5 | ||
四肢肌痛 | 62.63 | 8 | 27.64 | 8 | 28.83 | 6 | 28.57 | 7 | 43.28 | 6 | |
头痛 | 61.84 | 9 | 18.70 | 12 | 24.09 | 9 | 23.50 | 9 | 27.36 | 9 | |
其他 | 发热 | 2.35 | 18 | 3.25 | 18 | 2.19 | 18 | 3.23 | 18 | 2.49 | 18 |
疲劳 | 63.41 | 1 | 70.07 | 1 | 75.12 | 1 | 70.15 | 1 | |||
月经不调 | 18.29 | 14 | 33.33 | 7 | 14.60 | 13 | 11.98 | 13 | 12.94 | 13 |
Table 4 The incidence and ranking of symptoms and signs in patients with long COVID and fatigue,hair loss,memory,comprehension,and attention loss,insomnia,or low back pain
症状和体征 | 疲劳患者a(n=341) | 脱发患者b(n=123) | 记忆力理解力注意力降低患者c(n=274) | 失眠患者d(n=217) | 腰背痛患者e(n=201) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | 所占比例(%) | 排名 | ||
神经 | 记忆力理解力注意力降低 | 56.30 | 1 | 62.60 | 2 | 61.75 | 2 | 65.67 | 2 | ||
嗅觉味觉减退或丧失 | 11.73 | 13 | 17.89 | 14 | 14.96 | 12 | 11.06 | 15 | 12.94 | 14 | |
精神 | 失眠 | 47.80 | 2 | 47.15 | 3 | 48.91 | 4 | 52.24 | 3 | ||
情绪低落、焦虑、烦躁 | 40.76 | 5 | 45.53 | 4 | 53.28 | 2 | 57.60 | 3 | 44.28 | 5 | |
心血管 | 心慌、心悸 | 44.28 | 3 | 43.90 | 6 | 50.00 | 3 | 53.46 | 4 | 50.25 | 4 |
呼吸 | 咳嗽 | 31.96 | 6 | 22.76 | 9 | 25.18 | 8 | 28.57 | 6 | 30.35 | 7 |
呼吸急促困难 | 15.54 | 10 | 17.89 | 13 | 21.17 | 10 | 22.58 | 10 | 19.40 | 10 | |
鼻塞 | 15.54 | 11 | 22.76 | 10 | 20.07 | 11 | 18.43 | 11 | 14.93 | 12 | |
咽痛 | 15.54 | 12 | 13.82 | 15 | 13.14 | 14 | 11.98 | 14 | 15.42 | 11 | |
胃肠道 | 腹泻、腹痛 | 7.62 | 16 | 12.20 | 16 | 9.49 | 16 | 11.06 | 16 | 10.45 | 16 |
呕吐 | 2.64 | 17 | 4.88 | 17 | 3.28 | 17 | 3.23 | 17 | 2.49 | 17 | |
皮肤 | 脱发 | 23.57 | 7 | 28.10 | 7 | 26.73 | 8 | 27.36 | 8 | ||
皮疹 | 13.58 | 15 | 21.14 | 11 | 11.68 | 15 | 12.90 | 12 | 12.44 | 15 | |
肌肉骨骼肌 | 腰背痛 | 69.25 | 4 | 44.72 | 5 | 48.18 | 5 | 48.39 | 5 | ||
四肢肌痛 | 62.63 | 8 | 27.64 | 8 | 28.83 | 6 | 28.57 | 7 | 43.28 | 6 | |
头痛 | 61.84 | 9 | 18.70 | 12 | 24.09 | 9 | 23.50 | 9 | 27.36 | 9 | |
其他 | 发热 | 2.35 | 18 | 3.25 | 18 | 2.19 | 18 | 3.23 | 18 | 2.49 | 18 |
疲劳 | 63.41 | 1 | 70.07 | 1 | 75.12 | 1 | 70.15 | 1 | |||
月经不调 | 18.29 | 14 | 33.33 | 7 | 14.60 | 13 | 11.98 | 13 | 12.94 | 13 |
[1] |
NICE,RCGP,SIGN. COVID-19 rapid guideline:managing the long-term effects of COVID-19[EB/OL].(2020-12-18)[2023-11-23].
|
[2] |
|
[3] |
|
[4] |
张允旭,鞠萍,刘琪,等. 新型冠状病毒感染后综合征的研究进展[J]. 中国感染控制杂志,2023,22(9):1114-1120. DOI:10.12138/j.issn.1671-9638.20234314.
|
[5] |
关于印发新型冠状病毒感染诊疗方案(试行第十版)的通知[EB/OL].(2023-01-06)[2024-02-08].
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] | |
[15] | |
[16] |
赵丹丹,何萍,夏寒,等. 基于真实世界临床数据的恶性肿瘤流行病学调查研究[J]. 上海医学,2023,46(7):493-497. DOI:10.19842/j.cnki.issn.0253-9934.2023.07.015.
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
苏芗萌,王一帆,王智贤,等. 新型冠状病毒肺炎发生后遗症的病理生理机制研究进展[J]. 中国病理生理杂志,2022,38(8):1499-1506. DOI:10.3969/j.issn.1000-4718.2022.08.021.
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[1] | WANG Ting, WANG Haiyan, FU Wenjun. Effect of Chronic Atrophic Gastritis Treated with Different Acupuncture and Moxibustion Therapies: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(23): 2913-2920. |
[2] | WU Kairui, YE Yu, LI Jiaoyue, PEI Bei, LI Xuejun, CHENG Hongliang. A Multicenter Randomized Controlled Clinical Trial Study on the Effect of Piwei Peiyuan Decoction Combined with Acupuncture in the Treatment of Chronic Atrophic Gastritis with Intestinal Metaplasia [J]. Chinese General Practice, 2024, 27(20): 2466-2475. |
[3] | JING Guanning, ZOU Ying, ZHUO Xiaoqi, SHI Siyan, SONG Yingliu, YAO Mi, CHI Chunhua, LI Junxia. The Current Status and Factors Influencing Long-term Proton Pump Inhibitor Use and Deprescribing among Community Residents [J]. Chinese General Practice, 2024, 27(19): 2344-2351. |
[4] | JIANG Qixia, XIE Haoting, WANG Huajun, LI Xiuyun, ZHU Yuling, WANG Yaling, MIN Yan, WANG Ke. Effectiveness Analysis of Two Incontinence Care Plans Based on Guidelines for Elderly COVID-19 Patients with Incontinence [J]. Chinese General Practice, 2024, 27(18): 2212-2217. |
[5] | Primary Healthcare and Health Education Committee of the Guangdong Provincial Health Management Association, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine. Expert Recommendations on the Diagnosis, Treatment, and Care of Post-COVID-19 Conditions for Primary Health Services: Guangdong Province [J]. Chinese General Practice, 2024, 27(17): 2045-2063. |
[6] | XU Ziwei, CHENG Kangyao, GUI Li. A Scoping Review of Research on the Management of Surge Hospitals during a Major Infectious Disease Outbreak [J]. Chinese General Practice, 2024, 27(16): 2039-2044. |
[7] | YANG Lihong, ZHANG Chao, LI Zefang, YANG Chen, WANG Fei, DU Yuzheng, SHI Huiyan. A Case Registry Study of Acupuncture Treatment for Stroke: Data Elements and Definitions [J]. Chinese General Practice, 2024, 27(16): 2023-2032. |
[8] | LI Zidong, ZHU Lin. Clinical Characteristics and Risk Factors of Fatigue in COVID-19 during Recovery Period [J]. Chinese General Practice, 2024, 27(15): 1849-1854. |
[9] | QIN Yuan, XIAO Lingyong, YANG Huan, ZHANG Xinyu, LIU Yi, DAI Xiaoyu. Analysis of Randomized Controlled Trials Outcome Indicators of Acupuncture for Knee Osteoarthritis [J]. Chinese General Practice, 2024, 27(08): 995-1000. |
[10] | YANG Huajie, WANG Haoxiang, CHEN Yuncong, LIANG Xudong, WANG Jiaji, HUANG Xiang. Status and Influencing Factors of Mental Health of Community Medical Personnel during the Normalized Prevention and Control of COVID-19 [J]. Chinese General Practice, 2024, 27(07): 834-842. |
[11] | QIN Xiaoyu, ZHANG Binsen, ZHANG Xiaojia, LU Xiaoting, LIU Hongxin, WANG Chunai. Effect of Electroacupuncture on Inflammation Response and Ferroptosis in Rats Modeling Postoperative Cognitive Dysfunction [J]. Chinese General Practice, 2024, 27(06): 723-732. |
[12] | JIA Liyan, ZHAO Nengjiang, YAN Bing, ZHANG Zhihai, ZHAN Na, LIN Yuanbing, LIU Jianping, YANG Shuyu. Analysis of the Factors Impacting the Awareness and Utilization of Traditional Chinese Medicine Guidelines for Diabetes among Primary Care Practitioners [J]. Chinese General Practice, 2024, 27(05): 589-596. |
[13] | NING Lin, SUN Jianguang. Qizhuhuaji Formula in the Treatment of Precancerous Lesion of Hepatocellular Carcinoma: a Randomized Controlled Study [J]. Chinese General Practice, 2024, 27(03): 335-342. |
[14] | ZHENG Jinping, XUE Wujun, JU Chunrong, MA Jun, ZENG Xiaofeng. Identification of COVID-19 Infection in Vulnerable Population and Its Prevention and Treatment Perspectives [J]. Chinese General Practice, 2024, 27(02): 132-137. |
[15] | YANG Lichao, ZENG Huatang, HU Mengzhi, WU Liqun, TIAN Qiannan, WEI Liangzhou, ZHU Jiming, LIANG Wannian. Application of Modified SEIR Model in Epidemic Prevention and Control: a Real World Study [J]. Chinese General Practice, 2024, 27(01): 118-124. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||